VolitionRx Limited (VNRX)

VolitionRx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	11.77	20.73	10.87	20.58	19.44	16.97
Cash & Cash Equivalents	11.77	20.73	10.87	20.58	19.44	16.97
Cash Growth	17.59%	90.76%	-47.20%	5.85%	14.61%	26.36%
Receivables	0.13	0.24	0.07	0.01	0.01	0
Other Current Assets	1.56	0.88	1.23	1.39	0.88	0.59
Total Current Assets	13.47	21.85	12.17	21.98	20.33	17.56
Property, Plant & Equipment	5.75	6.07	6.01	5.29	5.5	3.36
Goodwill and Intangibles	0.22	0.02	0.11	0.22	0.32	0.37
Total Long-Term Assets	5.96	6.1	6.12	5.51	5.82	3.74
Total Assets	19.43	27.95	18.3	27.49	26.15	21.29
Accounts Payable	3.53	3.21	3.04	1.54	1.54	0.63
Deferred Revenue	23	23	10	0.01	0	0
Current Debt	1.4	1.45	1.36	1.02	1.08	1
Other Current Liabilities	3.57	4.17	2.99	3.94	3.62	2.23
Total Current Liabilities	31.49	31.84	17.39	6.52	6.24	3.86
Long-Term Debt	4.15	4.4	3.62	3	3.36	2.93
Other Long-Term Liabilities	0.41	0.42	0.42	0.25	0.26	0.3
Total Long-Term Liabilities	4.56	4.83	4.04	3.25	3.62	3.23
Total Liabilities	36.05	36.66	21.42	9.77	9.86	7.09
Total Debt	5.55	5.86	4.97	4.02	4.44	3.94
Debt Growth	16.36%	17.78%	23.80%	-9.56%	12.80%	20.56%
Retained Earnings	-210.94	-202.58	-167.26	-136.99	-110.17	-89.82
Comprehensive Income	0.26	0.24	0.23	0.15	-0.06	0.13
Shareholders' Equity	-15.61	-7.8	-2.57	17.94	16.34	14.2
Net Cash / Debt	6.22	14.87	5.89	16.56	15	13.03
Net Cash / Debt Growth	18.72%	152.34%	-64.42%	10.40%	15.16%	28.22%
Net Cash Per Share	0.08	0.21	0.11	0.31	0.33	0.33
Working Capital	-18.02	-9.98	-5.21	15.46	14.1	13.7
Book Value Per Share	-0.19	-0.11	-0.05	0.34	0.36	0.36

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).